Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction.

Published in:

Brazilian Journal of Infectious Diseases, 2023, v. 27, n. 3, p. 1, doi. 10.1016/j.bjid.2023.102757

By:

• Monteiro Matsuda, Elaine;
• Barros Campos, Ivana;
• Penteriche de Oliveira, Isabela;
• Rodrigues Colpas, Daniela;
• Silva López-Lopes, Giselle Ibete;
• Oliveira Chiavegato, Victor;
• de Macedo Brígido, Luís Fernando

Publication type:

Article